Professional Documents
Culture Documents
imports. Citing the achievement of the PPE manufacturing industry, he further said that it is a
matter of pride that India has built an entirely new industry making PPE kits worth hundreds
of crores of rupees in only a month.
Rs 2 lakh crore Concessional credit boost to 2.5 crore farmers through Kishan Credit Cards:
• Special drive to be undertaken to provide concessional credit to PM-KISAN
beneficiaries through Kishan Credit Cards
• Fishermen and Animal Husbandry farmers will also be included in this drive.
• This will enable such farmers to gain access to institutional
credit at concessional interest rate
• 2.5 crore farmers will be covered and will benefit from credit flow of about Rs 2 lakh
crores
Labour Codes - Benefits for Workers-
• Universalization of right of minimum wages and timely payment of wages to all
workers including unorganized workers – presently minimum wages applicable to
only 30% of workers.
• Statutory concept of National Floor Wage introduced: will reduce regional disparity
in minimum wages.
• Fixation of minimum wages simplified, leading to a smaller number of rates of
minimum wages and better compliance.
• Appointment letter for all workers- this will promote formalization.
• Annual Health Check-up for employees.
• Occupational Safety & Health (OSH) Code also applicable to establishments engaged
in work of hazardous nature even with threshold of less than 10 workers.
Medical Sector:
API
Pharmaceutical companies in India have been excessively relying on China for active
pharmaceutical ingredients (API) or bulk drugs and key starting materials (KSMs).
Approximately 68% of the API imports to India come from China. However, as the Covid-19
disrupted the supply chain, the companies have started exploring ways to move the supply
chain out of China to get rid of geographical vulnerability.
The supply chain disruptions hurt the Indian pharmaceutical companies the most because
India is the world’s largest exporter of generic formulation and API is the key ingredient to
develop generic formulation. As a result, pharmaceutical companies hope to insulate their
supply chains from such shock in future by becoming self-dependent.